Search
Hisun Pharmaceutical Receives FDA Clearance to Initiate Clinical Trials for Innovative Drug HSK47388 Tablets
2 day ago /
Read about 0 minute
Author：小编
Hisun Pharmaceutical has recently secured approval from the U.S. Food and Drug Administration (FDA) to commence clinical trials for its self-developed, innovative drug HSK47388 tablets. This oral medication boasts potent and highly selective properties, targeting the treatment of autoimmune diseases. Notably, in China, the Investigational New Drug (IND) application for HSK47388 was accepted in May 2025 and is presently undergoing rigorous review.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
